Cargando…

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa

Detalles Bibliográficos
Autores principales:	Pillay, D, Goodall, R, Gilks, CF, Yirrell, D, Gibb, D, Spyer, M, Kaleebu, P, Munderi, P, Kityo, C, McCormick, A, Nkalubo, J, Lyagoba, F, Chirara, M, Hakim, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The International AIDS Society 2010
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112833/ http://dx.doi.org/10.1186/1758-2652-13-S4-O20

Ejemplares similares

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Correction: Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial
por: Sutherland, Katherine A., et al.
Publicado: (2016)

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
por: Dolling, David I., et al.
Publicado: (2017)

Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa
por: Sutherland, Katherine A., et al.
Publicado: (2015)

Hepatitis B serological markers and plasma DNA concentrations
por: Price, Huw, et al.
Publicado: (2017)

Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe
por: Walker, AS, et al.
Publicado: (2010)

Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa
por: Goodall, Ruth L., et al.
Publicado: (2017)

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda
por: Goodall, R. L., et al.
Publicado: (2014)

A Single CD4 Test with 250 Cells/Mm(3) Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria
por: Gilks, Charles F., et al.
Publicado: (2013)

High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial
por: Kityo, Cissy, et al.
Publicado: (2014)

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
por: Walker, AS, et al.
Publicado: (2010)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study
por: Gomo, Zvenyika AR, et al.
Publicado: (2014)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

Sara García /
por: Baeza Lope Ileana
Publicado: (2018)

Effect of HIV-1 Subtypes on Disease Progression in Rural Uganda: A Prospective Clinical Cohort Study
por: Ssemwanga, Deogratius, et al.
Publicado: (2013)

Boosting Virology in Brazil
por: Pardini, Maria Inês de Moura Campos, et al.
Publicado: (2008)

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
por: Gupta, Ravindra K., et al.
Publicado: (2014)

Sara de Ur /
por: Jiménez Lozano, José
Publicado: (1989)

Sara de Ur /
por: Jiménez Lozano, José
Publicado: (1997)

1st Workshop of the Canadian Society for Virology
por: McCormick, Craig, et al.
Publicado: (2017)

From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults
por: Namakoola, Ivan, et al.
Publicado: (2016)

Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial
por: Gibb, Diana M., et al.
Publicado: (2012)

Draft Genome Sequences of Two Salmonella Strains from the SARA Collection, SARA64 (Muenchen) and SARA33 (Heidelberg), Provide Insight into Their Antibiotic Resistance
por: Kroft, Brenda S., et al.
Publicado: (2013)

Sara García : la abuelita del cine nacional

Grenoble: First beams at SARA
Publicado: (1982)

Clinical Interventions in Aging and SARA
por: Walker, Richard F
Publicado: (2006)

El libro de Sara
por: Hicks, Esther
Publicado: (2003)

Cuando Sara Chura despierte
por: Piñeiro, Juan Pablo, 1979-
Publicado: (2003)

First person – Sara Ibrahim
Publicado: (2020)

CSV2018: The 2nd Symposium of the Canadian Society for Virology
por: Grandvaux, Nathalie, et al.
Publicado: (2019)

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens
por: López-Cortés, Luis F., et al.
Publicado: (2016)

La otra Sara, o, La huída de Egipto
por: Harss, Luis, 1936-
Publicado: (1968)

Lack of effectiveness of adherence counselling in reversing virological failure among patients on long‐term antiretroviral therapy in rural Uganda
por: Birungi, J, et al.
Publicado: (2019)

Adaptation of advanced clinical virology assays from HIV-1 to SARS-CoV-2
por: McCormick, Kevin D., et al.
Publicado: (2021)

Grenoble : Premiers faisceaux à SARA
Publicado: (1982)

Involvement of SARA in Axon and Dendrite Growth
por: Arias, Cristina Isabel, et al.
Publicado: (2015)

BIOPHYTIS BIO101 IN SARCOPENIA: UPDATE ON THE SARA PROGRAM: FROM SARA-INT TOWARDS THE PHASE 3 STUDY
por: Tourette, Cendrine, et al.
Publicado: (2022)

Virological efficacy of PI monotherapy for HIV-1 in clinical practice
por: El Bouzidi, Kate, et al.
Publicado: (2016)

Nuclear spectroscopy of exotic nuclei with the SARA/IGISOL facility
por: Béraud, R, et al.
Publicado: (1994)

CD8(+) T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4(+) T Cells <200 Cell/μL: The DART Trial STI Substudy
por: Serwanga, Jennifer, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5d6vd1qhlpkfno3v5oifv4ddv2